Academic Radiology
Volume 17, Issue 5 , Pages 652-657 , May 2010

FDA & Digital Mammography: Why Has FDA Required Full Field Digital Mammography Systems to Be Regulated as Potentially Dangerous Devices for More Than 10 Years?

Received 27 January 2010 ,Accepted 27 January 2010.

References 

  1. Pisano E, Gatsonis C, Hendrick E, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 2005;353:1773–1783
  2. US Food and Drug Administration, Center for Devices and Radiological Health, Medical Devices Advisory Committee, Radiological Devices Panel. Available at: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/RadiologicalDevicesPanel/UCM197418.pdf. Accessed February 9, 2010.
  3. US Food and Drug Administration. FY 2008 performance report to the president and the Congress for the Prescription Drug User Fee Act. Silver Spring, MD: US Food and Drug Administration.
  4. US Food and Drug Administration. Premarket notification (510k). Available at: http://www.fda.gov/medicaldevices/deviceregulationandguidance/howtomarketyourdevice/premarketsubmissions/premarketnotification510k/default.htm. Accessed February 9, 2010.
  5. Tran V. The Radiation Control for Health and Safety Act of 1968: history, accomplishments, and future. Available at: http://leda.law.harvard.edu/leda/data/792/Tran06.pdf. Accessed February 9, 2010.
  6. Urban MA. The FDA's policy on seizures, injunctions, civil fines, and recalls. Food Drug Law J. 1992;47:411–412
  7. The development of the Medical Device Amendments: an interview with Peter Barton Hutt. Medical Device & Diagnostic Industry Magazine. May 1996;
  8. Schwartz JFDA. commissioner Kessler will resign early next year. The Washington Post. November 26, 1996;
  9. Pisano ED. Current status of full-field digital mammography. Radiology. 2000;214:26–28
  10. US Food and Drug Administration. Charter of the Science Board to the Food and Drug Administration. Available at: http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/ScienceBoardtotheFoodandDrugAdministration/ucm115356.htm. Accessed February 9, 2010.
  11. US Food and Drug Administration. Science Board meeting. Available at: http://www.fda.gov/ohrms/dockets/ac/01/transcripts/3799t1.htm. Accessed February 9, 2010.
  12. US Food and Drug Administration. Premarket applications for digital mammography systems; final guidance for industry and FDA. Available at: http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm073624.htm. Accessed February 9, 2010.
  13. US Food and Drug Administration. Draft guidance for industry and FDA staff: class II special controls guidance document: full field digital mammography system. Available at: http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm107552.htm. Accessed February 9, 2010.
  14. US Food and Drug Administration. FY 2010 all purpose table—budget authority. Available at: http://www.fda.gov/downloads/AboutFDA/ReportsManualsForms/Reports/BudgetReports/UCM153876.pdf. Accessed February 9, 2010.
  15. Institute of Medicine. Public health effectiveness of the FDA 510(k) clearance process. Available at: http://www.iom.edu/Activities/PublicHealth/510KProcess.aspx. Accessed February 9, 2010.
  16. Harris G. In F.D.A. files, claims of rush to approve devices. The New York Times. January 12, 2009.

 Mr Nields is chairman of Bioptics Inc, a company developing complementary metal-oxide semiconductor technology for applications that include full-field digital mammography.

PII: S1076-6332(10)00065-6

doi: 10.1016/j.acra.2010.01.012

Academic Radiology
Volume 17, Issue 5 , Pages 652-657 , May 2010